Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000325705 | SCV000340506 | uncertain significance | not provided | 2016-03-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001214468 | SCV001386151 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2022-07-06 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the POMGNT1 gene. It does not directly change the encoded amino acid sequence of the POMGNT1 protein. This variant is present in population databases (rs778376741, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with POMGNT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 286911). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |